{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:10:44Z","timestamp":1793376644015,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR001871"],"award-info":[{"award-number":["TL1 TR001871"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10815-018-1203-8","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T06:17:41Z","timestamp":1533017861000},"page":"1861-1868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4703-3937","authenticated-orcid":false,"given":"N.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Letourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Imbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mok-Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. I.","family":"Cedars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell P.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"1203_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/humupd\/dms022","volume":"18","author":"S Morgan","year":"2012","unstructured":"Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update Oxford Univ Press. 2012;18:525\u201335.","journal-title":"Hum Reprod Update Oxford Univ Press"},{"issue":"7","key":"1203_CR2","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/cncr.26403","volume":"118","author":"Joseph M. Letourneau","year":"2011","unstructured":"Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer Wiley Subscription Services, Inc., A Wiley Company; 2012;118:1933\u20139.","journal-title":"Cancer"},{"key":"1203_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10549-005-9059-x","volume":"96","author":"WJ Kil","year":"2006","unstructured":"Kil WJ, Ahn SD, Shin SS, Lee S-W, Choi EK, Kim JH, et al. Treatment-induced menstrual changes in very young (<35 years old) breast cancer patients. Breast Cancer Res Treat. 2006;96:245\u201350.","journal-title":"Breast Cancer Res Treat"},{"key":"1203_CR4","doi-asserted-by":"crossref","unstructured":"D\u2019Avila \u00c2M, Capp E, Corleta HVE. Antral follicles count and anti-M\u00fcllerian hormone levels after gonadotoxic chemotherapy in patients with breast cancer: cohort study. Rev Bras Ginecol Obstet. Thieme-Revinter Publica\u00e7\u00f5es Ltda; 2017.","DOI":"10.1055\/s-0037-1601438"},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1210\/jc.2010-2582","volume":"96","author":"RA Anderson","year":"2011","unstructured":"Anderson RA, Cameron DA. Pretreatment serum anti-M\u00fcllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab. 2011;96:1336\u201343.","journal-title":"J Clin Endocrinol Metab"},{"key":"1203_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.fertnstert.2009.02.043","volume":"94","author":"M Rosendahl","year":"2010","unstructured":"Rosendahl M, Andersen CY, la Cour FN, Juul A, L\u00f8ssl K, Andersen AN. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril. 2010;94:156\u201366.","journal-title":"Fertil Steril"},{"key":"1203_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","volume":"31","author":"R Fleming","year":"2015","unstructured":"Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone. Reprod BioMed Online. 2015;31:486\u201396.","journal-title":"Reprod BioMed Online"},{"key":"1203_CR8","unstructured":"Letourneau JM, Cakmak H, Quinn M, Sinha N, I Cedars M, Rosen MP. Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield. J Assist Reprod Genet. Springer US; 2017;103:1551\u20138."},{"key":"1203_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1210\/jcem-42-4-629","volume":"42","author":"BM Sherman","year":"1976","unstructured":"Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab. 1976;42:629\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"1203_CR10","first-page":"1808","volume":"96","author":"K Lutchman Singh","year":"2007","unstructured":"Lutchman Singh K, Muttukrishna S, Stein RC, McGarrigle HH, Patel A, Parikh B, et al. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer Nat Publ Group. 2007;96:1808\u201316.","journal-title":"Br J Cancer Nat Publ Group"},{"issue":"10","key":"1203_CR11","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.23071","volume":"110","author":"Ozgur Oktem","year":"2007","unstructured":"Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. Wiley Subscription Services, Inc., A Wiley Company; 2007;110:2222\u20139.","journal-title":"Cancer"},{"key":"1203_CR12","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/humrep\/del201","volume":"21","author":"RA Anderson","year":"2006","unstructured":"Anderson RA, Themmen APN, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod Oxford Univ Press. 2006;21:2583\u201392.","journal-title":"Hum Reprod Oxford Univ Press"},{"key":"1203_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.fertnstert.2012.09.039","volume":"99","author":"KE Dillon","year":"2013","unstructured":"Dillon KE, Sammel MD, Prewitt M, Ginsberg JP, Walker D, Mersereau JE, et al. Pretreatment antim\u00fcllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013;99:477\u201383.","journal-title":"Fertil Steril"},{"key":"1203_CR14","unstructured":"Wenners A, Grambach J, Koss J, Maass N, Jonat W, Schmutzler A, et al. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial. BMC Cancer. 3rd ed. BioMed Central; 2017;17:632."},{"key":"1203_CR15","first-page":"16","volume":"35","author":"H Lindsey","year":"2013","unstructured":"Lindsey H. ASCO Updates Fertility-Preservation Guidelines. Oncol Times. 2013;35:16\u20137.","journal-title":"Oncol Times"},{"key":"1203_CR16","first-page":"269","volume":"306","author":"L Del Mastro","year":"2011","unstructured":"Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA Am Med Assoc. 2011;306:269\u201376.","journal-title":"JAMA Am Med Assoc"},{"key":"1203_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1413204","volume":"372","author":"HCF Moore","year":"2015","unstructured":"Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med Mass Med Soc. 2015;372:923\u201332.","journal-title":"N Engl J Med Mass Med Soc"},{"key":"1203_CR18","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","volume":"29","author":"B Gerber","year":"2011","unstructured":"Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29:2334\u201341.","journal-title":"J Clin Oncol"},{"key":"1203_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1200\/JCO.2011.34.6890","volume":"30","author":"PN Munster","year":"2012","unstructured":"Munster PN, Moore AP, Ismail-Khan R, Cox CE, Lacevic M, Gross-King M, et al. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol. 2012;30:533\u20138.","journal-title":"J Clin Oncol"},{"key":"1203_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","volume":"121","author":"EA Elgindy","year":"2013","unstructured":"Elgindy EA, El-Haieg DO, Khorshid OM, Ismail EI, Abdelgawad M, Sallam HN, et al. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial. Obstet Gynecol. 2013;121:78\u201386.","journal-title":"Obstet Gynecol"},{"key":"1203_CR21","first-page":"141","volume":"12","author":"L Giuseppe","year":"2007","unstructured":"Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematol Taylor & Francis. 2007;12:141\u20137.","journal-title":"Hematol Taylor & Francis"},{"key":"1203_CR22","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s10815-015-0575-2","volume":"32","author":"JL Chan","year":"2015","unstructured":"Chan JL, Johnson LNC, Efymow BL, Sammel MD, Gracia CR. Outcomes of ovarian stimulation after treatment with chemotherapy. J Assist Reprod Genet Springer US. 2015;32:1537\u201345.","journal-title":"J Assist Reprod Genet Springer US"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-018-1203-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-018-1203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-018-1203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:28:43Z","timestamp":1589718523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-018-1203-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1007\/s10815-018-1203-8","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of California, San Francisco (UCSF) Committee on Human Research and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}